secwatch.observer — SEC 8-K summary
======================================

Issuer:     Lexaria Bioscience Corp. (LEXX)
CIK:        0001348362
Form:       8-K
Filed at:   2025-04-28T23:59:59+00:00
Accession:  0001640334-25-000711
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 1.01, 3.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Lexaria raises $2M via registered direct offering of common stock and pre-funded warrants
--------------------------------------------------------------------------------

- Gross proceeds $2M from sale of 2M shares/pre-funded warrants at $1.00 per share to one institutional investor.
- No new warrants issued to investor other than pre-funded warrants; placement agent gets 70,000 warrants at $1.25.
- Offering closed April 28, 2025; net proceeds for working capital and general corporate purposes.
- CEO states transaction minimized dilution during uncertain market; H.C. Wainwright acted as exclusive placement agent.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1348362/000164033425000711/0001640334-25-000711-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1348362/000164033425000711/lxrp_8k.htm
  HTML page:      https://secwatch.observer/filing/0001640334-25-000711

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer